PMN 0.99 (-5.71%)
CA74346M4065BiotechnologyBiotechnology

ProMIS Neurosciences (PMN) Stock Highlights

0.99 | -5.71%
2024-10-19 05:58:37
ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimers disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinsons disease, and dementia with Lewy bodies. It primarily operates in Canada.

Statistics

Range Today
0.99 1.04
Volume Today 27.61K
Range 1 Year
0.95 3.1
Volume 1 Year 14.98M
Range 3 Year
0.95 9.8
Volume 3 Year 39.61M
Range 10 Year
0.95 42
Volume 10 Year 42.98M

Highlights

Market Capitalization 29.59M (micro)
Floating Shares 14.83M
Current Price 0.99
Price To Earnings -1.89
Earnings Per Share -0.54
Payout Ratio 0%

Performance

Latest -5.71%
1 Month -29.79%
3 Months -53.3%
6 Months -48.7%
1 Year -46.77%
3 Years -89%
5 Years -89%
10 Years -91.32%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.